{"disease":{"id":"spinal-disease","name":"spinal disease"},"drugs":{"marketed":[{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with cerebrospinal fluid leak and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with HIV infection and sickle cell disease and cerebrospinal fluid leak and cochlear implant and other conditions that increase the risk of invasive pneumococcal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":18,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT04956653","title":"Social Characteristics of Hospitalized Patients With Spinal Degenerative Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":32502,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT06607081","title":"Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT04877470","title":"Baseline-characteristics of Patients Referred to a Secondary Spine Centre","phase":"","overall_status":"COMPLETED","enrollment_count":4855,"lead_sponsor_name":"Zuyderland Medisch Centrum","has_results":false},{"nct_id":"NCT02980822","title":"Patient Reported Outcome After Surgical Treatment of DDD in Scandinavia","phase":"","overall_status":"COMPLETED","enrollment_count":3500,"lead_sponsor_name":"Spine Centre of Southern Denmark","has_results":false},{"nct_id":"NCT05181098","title":"Prospective Robotic-Guided Registry of Spine Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"The National Spine Health Foundation","has_results":false},{"nct_id":"NCT05299762","title":"A Post Market Surveillance on INFUSE Bone Graft","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Medtronic Spinal and Biologics","has_results":false},{"nct_id":"NCT02138344","title":"Assessment of Neuropathic Pain","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT04141891","title":"Advancing Understanding of Transportation Options","phase":"NA","overall_status":"COMPLETED","enrollment_count":529,"lead_sponsor_name":"University of Colorado, Denver","has_results":true},{"nct_id":"NCT06828068","title":"Using Radiation-free Ultrasound for Screening Scoliosis Among Female School Children in Hong Kong to Reduce Unnecessary X-ray Exposure","phase":"NA","overall_status":"COMPLETED","enrollment_count":442,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04631471","title":"Regeneration in Cervical Degenerative Myelopathy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT04983576","title":"Risk Factors for Mechanical Failure After Spinal Fusion : an Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":393,"lead_sponsor_name":"Istituto Ortopedico Rizzoli","has_results":false},{"nct_id":"NCT03024749","title":"Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas","phase":"","overall_status":"UNKNOWN","enrollment_count":380,"lead_sponsor_name":"Hongqi Zhang, MD","has_results":false},{"nct_id":"NCT05659121","title":"Improving Mobility Via Robotic Exoskeletons in Local Rehabilitation Settings in Singapore","phase":"NA","overall_status":"COMPLETED","enrollment_count":375,"lead_sponsor_name":"National University Hospital, Singapore","has_results":false},{"nct_id":"NCT06838975","title":"Virtual Reality Rehabilitation for Cognitive, Emotional, and Motor Recovery in Neurological Disorders","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":328,"lead_sponsor_name":"IRCCS Centro Neurolesi Bonino Pulejo","has_results":false},{"nct_id":"NCT06891690","title":"Use of TDCS Stimulation in Neurological and Gynaecological Conditions","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Poznan University of Physical Education","has_results":false},{"nct_id":"NCT00629642","title":"Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT03593330","title":"Neurosurgical Transitional Care Programme","phase":"NA","overall_status":"TERMINATED","enrollment_count":242,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT04481269","title":"A Prospective Randomized Controlled Study on the Clinical Efficacy of a New Surface Modified Composite Coating Orthopedic Implant Device","phase":"NA","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05626855","title":"Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":238,"lead_sponsor_name":"Scholar Rock, Inc.","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT04839783","title":"Single Position Spine Surgery Registry","phase":"","overall_status":"TERMINATED","enrollment_count":234,"lead_sponsor_name":"Spine and Scoliosis Research Associates","has_results":false},{"nct_id":"NCT04467944","title":"Effect of Pre-existing Adjacent Segment Degeneration on Long-term Effectiveness After Lumbar Fusion Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT05375201","title":"Clinical Decision-Making and Virtual Reality Exercise","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT04469387","title":"Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT05744310","title":"Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT03533010","title":"Preventing Curve Progression and the Need for Bracing in Adolescent Idiopathic Scoliosis With Calcium + Vitamin D Supplementation","phase":"NA","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05156320","title":"Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Scholar Rock, Inc.","has_results":false},{"nct_id":"NCT02341950","title":"Clinical Trial of a Serious Game for Individuals With SCI/D","phase":"NA","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT07364773","title":"Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Shirley Ryan AbilityLab","has_results":false},{"nct_id":"NCT05506657","title":"Early Intervention to Promote Return to Work for People With Spinal Cord Injury","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":162,"lead_sponsor_name":"Kessler Foundation","has_results":false},{"nct_id":"NCT07180940","title":"Comparison of Perineural Dexamethasone Versus Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Lumbar Spine Surgery: A Randomized, Double-blind, Controlled Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Poznan University of Medical Sciences","has_results":false},{"nct_id":"NCT03127514","title":"AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"Amylyx Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT03969602","title":"Cognitive Behavioral Therapy (CBT) After Lumbar Spinal Fusion in Patients With High Pain Catastrophizing","phase":"NA","overall_status":"UNKNOWN","enrollment_count":126,"lead_sponsor_name":"Neurocenter of Southern Switzerland","has_results":false},{"nct_id":"NCT03515122","title":"The Swedish Spinal Cord Injury Study on Cardiopulmonary and Autonomic Impairment","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT05029726","title":"Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":125,"lead_sponsor_name":"John O'Toole","has_results":false},{"nct_id":"NCT05214235","title":"A Clinical Study on the Effect of Hypoglycemic Drugs on the Prognosis of Spinal Surgery in Diabetic Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":124,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT04775537","title":"OssiMend BA in Posterolateral Instrumented Lumbar Fusion","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Collagen Matrix","has_results":false},{"nct_id":"NCT06407167","title":"Neuropathic Pain in Patients With Degenerative Lumbar Stenosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"N.N. Priorov National Medical Research Center of Traumatology and Orthopedics","has_results":false},{"nct_id":"NCT00001364","title":"Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT03797378","title":"Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT03158766","title":"Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID)","phase":"","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT05148637","title":"General Anesthesia and Regional Cerebral Oxygenation inSpine Surgery Prone Position","phase":"NA","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT03832036","title":"The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Spine Centre of Southern Denmark","has_results":false},{"nct_id":"NCT05970367","title":"Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"KU Leuven","has_results":false},{"nct_id":"NCT05183152","title":"Non-invasive BCI-controlled Assistive Devices","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT05610098","title":"Gene Expression Profiles in Spinal Tuberculosis.","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT05182489","title":"Adaptix RCT Evaluating Adaptix™ Versus PEEK Cages","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Ohio State University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}